Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 1

Status

Recruiting 30Active not recruiting 30Completed 11Terminated 8Withdrawn 6Unknown 6Not yet recruiting 4

Sponsor Class

OTHER 6

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Gynecologic 4Thoracic 2Other solid neoplasm 2

Conditions

Ovarian Neoplasms 2Endometrial Neoplasms 2Mesothelioma, Malignant 1Mesothelioma 1Lung Neoplasms 1Fallopian Tube Neoplasms 1

Interventions

Cisplatin 512Radiotherapy 376Cyclophosphamide 361Carboplatin 354Capecitabine 341Oxaliplatin 331Paclitaxel 328Gemcitabine 318Docetaxel 314Fluorouracil 288Drug Therapy 271apatinib 245Bevacizumab 243camrelizumab 217Etoposide 200Irinotecan 182Doxorubicin 180Leucovorin 160Dexamethasone 160pembrolizumab 150sintilimab 143Neoadjuvant Therapy 142anlotinib 139Pemetrexed 138Cytarabine 138Blood Specimen Collection 138Surgical Procedures, Operative 130toripalimab 128Radiosurgery 127S 1 (combination) 124

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Unknown × dostarlimab × Clear all
NCT05728814 2024-02-23

DORA

Grupo Español de Investigación en Cáncer de Ovario

Unknown
100 enrolled
Gynecologic

Endometrial Neoplasms

NCT03016338 2024-01-30

Study of Niraparib and TSR-042 in Recurrent Endometrial Cancer

University Health Network, Toronto

Phase 2 Unknown
51 enrolled
Gynecologic

Endometrial Neoplasms

NCT05065021 2024-01-17

Using Genetic Profile to Determine the Treatment for Patients With Ovarian Cancer Who Previously Received a PARP-inhibitor

University Health Network, Toronto

Phase 2 Unknown
40 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT04940637 2023-05-12

UNITO-001

University of Turin, Italy

Phase 2 Unknown
70 enrolled
Other solid neoplasmThoracic

Lung Neoplasms, Mesothelioma

NCT03654833 2023-03-14

MiST

University of Leicester

Phase 2 Unknown
186 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT04679064 2021-08-27

NItCHE-MITO33

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase 3 Unknown
427 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡